RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

 

RAPS is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization.

Stay informed on the latest healthcare regulatory news through RAPS’ online magazine, Regulatory Focus and its companion daily e-newsletter RF Today, or by following RAPS on social media, including TwitterLinkedIn and Facebook.

Reporters, bloggers and other members of the media interested in covering RAPS events or programs should contact Zachary Brousseau, senior manager of communications, at zbrousseau@raps.org or by calling +301 770 2920 ext. 245.

Press Releases

RAPS Welcomes Germany Chapter

Posted 16 April 2020 | By Zachary Brousseau 

RAPS announced the official launch of the RAPS Germany Chapter, bringing the worldwide total to 19 chapters and eight local networking groups.

A Record-High 362 Regulatory Professionals Pass the RAC Exam

Posted 03 February 2020 | By Zachary Brousseau 

A record-high 362 regulatory professionals have passed the Regulatory Affairs Certification (RAC) exam during the most recent RAC exam period, RAPS announced today.

RAPS 2020 Board Begins Term, Welcomes Trautman, Pokrop and Hoekstra

Posted 23 January 2020 | By Zachary Brousseau 

The RAPS board of directors of officially began its 2020 term on 1 January. Don Boyer, a former top Health Canada official who is now a private regulatory consultant, is serving his second ye...

RAPS Welcomes Colorado Chapter

Posted 17 October 2019 | By Zachary Brousseau 

RAPS has announced the official launch of the RAPS Colorado Chapter. Chapter leaders and other representatives attended RAPS’ recent Regulatory Convergence in Philadelphia, where they were wel...

RAPS Honors Four New Fellows

Posted 24 September 2019 | By Zachary Brousseau 

RAPS today honored the 2019 class of RAPS Fellows, a distinction bestowed upon seasoned regulatory leaders who have gone above and beyond to give back to the profession and share their experie...

New EU regulatory changes are coming: Here’s what you need to know
by Fink Densford, Medical Design & Outsourcing, 2 January 2019
---
HHS Recommends Co-Prescribing Naloxone With Opioids
by  Joyce Frieden,  Medpage Today, 20 December 2018

Medtech Losers of 2019
by  MDDI Staff,  Medical Device and Diagnostics Industry, 17 December 2019

Waiting in the shadow of a no deal Brexit
Manufacturing Chemist, 19 December 2018

MDR: Market disruption on the horizon
MedTech Engine​, 11 December 2018

FDA Approves NIH-Funded Genetic Database, Issues Draft Guidance on NASH
Pharmacy Choice, 7 December 2018

Disruption of the Year: EU regulatory overhaul
by  Meg Bryant,  MedTechDive, 3 December 2018